We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Applying for an individual domestic drugs licence to prescribe cocaine, diamorphine and dipipanone for the treatment of addiction.
The Accelerated Access Review aims to speed up access to innovative drugs, devices and diagnostics for NHS patients.
The MHRA will introduce a patient alert card to increase awareness among men taking finasteride about potential psychiatric and sexual side effects
Find out about MCA's recruitment process for approved doctors (ADs).
Advice and guidance on the health needs of migrant patients for healthcare practitioners.
Lists of English-speaking doctors, medical facilities and practitioners around the world to help British people abroad access healthcare.
Information for British people on medical support in Thailand including mental health, lists of hospitals and care homes and how the British embassy can help.
FCDO travel advice for the Turks and Caicos Islands. Includes safety and security, insurance, entry requirements and legal differences.
The Advisory Committee on Releases to the Environment advises government on requests for permission to release genetically modified organisms (GMO) into the environment.
How to notify the MHRA of your intention to carry out a clinical investigation for medical devices.
Healthcare professionals prescribing montelukast should be alert to the risk of neuropsychiatric reactions in all patients including children and adolescents. Reported neuropsychiatric reactions include sleep disorders, hallucinations, anxiety and depression, as well as changes in behaviour and mood. Healthcare professionals...
The review of the safety of isotretinoin has concluded.
Information for healthcare professionals on pertussis (whooping cough).
Safety leaflet on topical corticosteroids and withdrawal reactions to help patients and their carers to use these medicines safely.
A list of overseas-based approved doctors for UK seafarers.
Further measures to be introduced to ensure patients who are prescribed montelukast for the treatment of asthma are informed of the risk of neuropsychiatric reactions
Guidance for industry and organisations to follow from 1 January 2021.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. We’ll send you a link to a feedback form. It will take only 2 minutes to fill in. Don’t worry we won’t send you spam or share your email address with anyone.